CYP3A4 and adenoma: Conversely, inhibitors of CYP3A4 (e.g., diltiazem and fluoxetine) can prolong dexamethasone bioavailability, which can suppress ACTH production by adenomas that are sensitive to negative feedback and thus lead to false-negative results (13, 20).